lifestyle.capitolhilltimes.com

Author: Rx Communications Group

Alexandria Real Estate Equities, Inc. Announces Tax Treatment of Year 2025 Distributions

January 23, 2026
MetaVia Announces the Closing of $9.3 Million Underwritten Public Offering, Including Full Exercise of Allotment Option

January 23, 2026
MetaVia Announces the Pricing of $8.1 Million Underwritten Public Offering

January 15, 2026
MetaVia Reports Positive Statistically Significant Results from Its Phase 1b Clinical Trial of DA-1726 In Metabolic Disease – Demonstrating Strong Glycemic Response, Significant Direct Hepatic Effects, Robust Weight Loss and Favorable Safety Profile

January 5, 2026
Alexandria Real Estate Equities, Inc. Celebrates 32 Years of Pioneering Leadership in Life Science Real Estate and Consequential Impact on Advancing Human Health

January 5, 2026
MetaVia to Participate in and Sponsor the 10th Annual MASH-TAG 2026 Conference

December 29, 2025
MetaVia Regains Compliance with Nasdaq Minimum Bid Price Requirement

December 22, 2025
Alexandria Real Estate Equities, Inc. to Hold Its Fourth Quarter and Year End 2025 Operating and Financial Results Conference Call and Webcast on January 27, 2026

December 9, 2025
Alexandria Real Estate Equities, Inc. Refreshes and Extends Its $500 Million Common Stock Repurchase Program

December 8, 2025
Alexandria Real Estate Equities, Inc. Declares Cash Dividend of $0.72 per Common Share for 4Q25, a Decrease of $0.60, or 45%, Compared to 3Q25

December 4, 2025